Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [709]

Long-term survival after laparoscopic versus open resection for colorectal...

Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway

Long-term survival after laparoscopic versus open resection for colorectal liver metastases ( Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway )

No difference in survival between laparoscopic surgery and open surgery in...

Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway

No difference in survival between laparoscopic surgery and open surgery in colorectal cancer patients with liver metastases ( Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway )

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer...

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer with focus on intermediate IMDC-risk population ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

KEYNOTE-062 study: Pembrolizumab as treatment for advanced gastroesophageal...

Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital, Barcelona...

KEYNOTE-062 study: Pembrolizumab as treatment for advanced gastroesophageal junction and gastric cancers ( Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )

Comment: Reasonable to conclude that pembrolizumab is non-inferior to...

Dr Richard Schilsky and Dr Josep Tabernero

Comment: Reasonable to conclude that pembrolizumab is non-inferior to chemotherapy ( Dr Richard Schilsky and Dr Josep Tabernero )

Pembrolizumab comparable to chemotherapy for patients with advanced gastric or...

Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital , Barcelona...

Pembrolizumab comparable to chemotherapy for patients with advanced gastric or gastroesophageal junction cancers ( Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital , Barcelona, Spain )

IMPACT: Improving Management of Advanced Colorectal Tumours

Mr Steve Clark, Patient Advocate for Bowel Cancer UK and Expert Patient for...

IMPACT: Improving Management of Advanced Colorectal Tumours ( Mr Steve Clark, Patient Advocate for Bowel Cancer UK and Expert Patient for ACPGBI )

Pre-operative radiation for pancreatic cancer

Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA

Pre-operative radiation for pancreatic cancer ( Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA )

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk ( Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA )

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus...

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

Colorectal cancer in the young: What do we know and what can we do?

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Colorectal cancer in the young: What do we know and what can we do? ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

More from ecancer